NeuraSignal is transforming stroke care with real-time access to cerebral blood flow—empowering clinicians to detect and prevent strokes with speed, accuracy, and automation.
At the core of our mission is a bold belief: Eliminating stroke begins with real-time brain data, accessible to any provider, anywhere. Powered by AI and robotics, our flagship platform—NovaGuide 2 (NG2)—delivers hands-free, autonomous transcranial Doppler (TCD) exams for the detection of right-to-left shunts (RLS), emboli, and cerebral vasospasm.
Why it matters: up to 30% of strokes are cryptogenic, and traditional tools like TTE miss most PFOs. NG2 detects 3x more PFOs than standard echo and identifies 2.7x more treatable shunts, giving clinicians the clarity to act—and patients the chance to prevent a second stroke.
Fully reimbursable under existing CPT codes (93886, 93892, 93893), NG2 brings diagnostic-grade neurovascular imaging to hospitals, ASCs, stroke centers, and rural clinics—without relying on specialized techs.
Join us in redefining stroke care. Because better brain health starts with blood flow at your fingertips.
Company Details
- Employees
- 37
- Address
- 1109 Westwood Blvd, Los Angeles,california 90024,united States
- Industry
- Medical Device
- Website
- neuralanalytics.com
- Keywords
- Ultrasound, Data Science, Stroke, AI, Cloud, neurology, neurologist, medtech, medical device.
- HQ
- Los Angeles, California
Neurasignal Questions
Neurasignal's website is neuralanalytics.com
Neurasignal's LinkedIn profile is https://www.linkedin.com/company/neurasignal
Neurasignal has
37 employees.
View email and phone details for 37
employees at Neurasignal.
Neurasignal's industry is
Medical Device
Neurasignal's top competitors are
Flintrehab,
Bioness Medical, Inc.,
Kandu,
Mindmaze,
Saebo, Inc.,
Bioventus,
Motus Nova,
Neofect,
Neuro Rehab Vr,
Tyromotion.
Neurasignal's categories are Medical Device
